Completed OBSERVATIONAL NCT01513538

Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function

TherapyGuide : Analysis of the Acceptance and Changes to Parameters Programming Suggested by the TherapyGuide Function

Sponsor: Medtronic

Updated 11 times since 2017 Last updated: Jun 30, 2025 Started: May 31, 2011 Primary completion: Oct 31, 2013 Completion: Oct 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01513538, this observational or N/A phase trial focuses on Bradyarrhythmia and remains completed. Sponsored by Medtronic, it has been updated 11 times since 2011, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

11 versions recorded

Aug 2025 — Present [monthly]

Completed
Jul 2025 — Aug 2025 [monthly]

Completed
Sep 2024 — Jul 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2023 — Jul 2024 [monthly]

Completed

▶ Show 6 earlier versions

Dec 2022 — Jan 2023 [monthly]

Completed
Jan 2021 — Dec 2022 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2018 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Jan 2018 [monthly]

Completed NA

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic
Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Marseille, France